GCL is the rate-limiting enzyme in glutathione biosynthesis and genetic polymorphisms in its catalytic (GCLC) and modifying (GCLM) subunits were associated with increased susceptibility to oxidative stress and with increased MI risk in the general population and T2D patients [96]. Here, GCLC is linked to type 2 diabetes mellitus.